SingularityNET (AGI) Easy 85%+ Target Mapped
Updated
Right now, SingularityNET (AGIBTC) is moving above EMA300...
With prices trading above EMA300 for AGIBTC, we can easily see strong additional growth.
Supporting this strong bullish signal, we also have a bullish MACD above zero and RSI.
Conditions for change
On a drop, EMA50/EMA100 are the most important levels in this timeframe...
Remember that you need a plan/strategy before you trade.
Make sure to do your own research and diversify as well.
Patience is key... Once you have buy-in, waiting can be a great tool to help you succeed.
Namaste.
- We see EMA300 as a very strong resistance level for altcoins pairs when looking at the daily trading...
- Conquering this level, moving and closing above it, becomes a strong bullish signal.
With prices trading above EMA300 for AGIBTC, we can easily see strong additional growth.
Supporting this strong bullish signal, we also have a bullish MACD above zero and RSI.
Conditions for change
On a drop, EMA50/EMA100 are the most important levels in this timeframe...
Remember that you need a plan/strategy before you trade.
Make sure to do your own research and diversify as well.
Patience is key... Once you have buy-in, waiting can be a great tool to help you succeed.
Namaste.
Note
First target hit... More is coming.Note
Targets:1) 0.00000230 |Hit 20-July (+17%)
2) 0.00000265 |Hit 5-Aug. (+34%)
3) 0.00000285 |Hit 8-Aug. (+45%)
4) 0.00000315 |Hit 9-Aug. (+60%)
5) 0.00000360 |Hit 10-Aug. (+83%)
6) 0.00000400 |Hit 10-Aug. (+103%)
7) 0.00000455 |Hit 10-Aug. (+131%)
8) 0.00000525 |Hit 21-Aug. (+166%)
9) 0.00000615 |Hit 22-Aug. (+212%)
10) 0.00000735 |Hit 23-Aug. (+273%)
🔝 Daily Cryptocurrency Technical Analysis
followalan.com
🔥 PREMIUM Trade-Numbers (6-In-1 Offer Now Live!)
lamatrades.com (Since 2017)
🚨 Free PREMIUM Trade-Numbers
alansantanatrades.com
followalan.com
🔥 PREMIUM Trade-Numbers (6-In-1 Offer Now Live!)
lamatrades.com (Since 2017)
🚨 Free PREMIUM Trade-Numbers
alansantanatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.